+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Breast Cancer Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 362126
  • Report
  • 150 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Astrazeneca Plc
  • Celgene Corporation
  • Eisai Co.
  • Eli Lilly and Company
  • Novartis International Ag
  • Pfizer
  • MORE
The Breast Cancer Therapeutics market worldwide is projected to grow by US$13.1 Billion, driven by a compounded growth of 9%. Hormone Drugs, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$5.8 Billion by the year 2025, Hormone Drugs will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$452.2 Million to the region's size and clout in the next 5 to 6 years. Over US$380.9 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Hormone Drugs will reach a market size of US$322 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.4% over the next couple of years and add approximately US$3.7 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AstraZeneca PLC
  • Celgene Corporation
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Novartis International AG
  • Pfizer, Inc.
  • Roche Diagnostics
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astrazeneca Plc
  • Celgene Corporation
  • Eisai Co.
  • Eli Lilly and Company
  • Novartis International Ag
  • Pfizer
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Breast Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Breast Cancer Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Breast Cancer Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Breast Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Hormone Drugs (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Hormone Drugs (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Hormone Drugs (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Chemotherapy Drugs (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Chemotherapy Drugs (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Chemotherapy Drugs (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Targeted Drug Therapy (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Targeted Drug Therapy (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Targeted Drug Therapy (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Breast Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 13: United States Breast Cancer Therapeutics Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 14: Breast Cancer Therapeutics Market in the United States by Product: A Historic Review in US$ Million for 2009-2017

TABLE 15: United States Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

CANADA

TABLE 16: Canadian Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 17: Canadian Breast Cancer Therapeutics Historic Market Review by Product in US$ Million: 2009-2017

TABLE 18: Breast Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

JAPAN

TABLE 19: Japanese Market for Breast Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 20: Breast Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 21: Japanese Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

CHINA

TABLE 22: Chinese Breast Cancer Therapeutics Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 23: Breast Cancer Therapeutics Historic Market Analysis in China in US$ Million by Product: 2009-2017

TABLE 24: Chinese Breast Cancer Therapeutics Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Breast Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 25: European Breast Cancer Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 26: Breast Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 27: European Breast Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: European Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 29: Breast Cancer Therapeutics Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 30: European Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

FRANCE

TABLE 31: Breast Cancer Therapeutics Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 32: French Breast Cancer Therapeutics Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 33: French Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

GERMANY

TABLE 34: Breast Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 35: German Breast Cancer Therapeutics Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 36: German Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

ITALY

TABLE 37: Italian Breast Cancer Therapeutics Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 38: Breast Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Product: 2009-2017

TABLE 39: Italian Breast Cancer Therapeutics Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 40: United Kingdom Market for Breast Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 41: Breast Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 42: United Kingdom Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

SPAIN

TABLE 43: Spanish Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 44: Spanish Breast Cancer Therapeutics Historic Market Review by Product in US$ Million: 2009-2017

TABLE 45: Breast Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

RUSSIA

TABLE 46: Russian Breast Cancer Therapeutics Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 47: Breast Cancer Therapeutics Market in Russia by Product: A Historic Review in US$ Million for 2009-2017

TABLE 48: Russian Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 49: Rest of Europe Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 50: Breast Cancer Therapeutics Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 51: Rest of Europe Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 52: Asia-Pacific Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 53: Breast Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 54: Asia-Pacific Breast Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 55: Breast Cancer Therapeutics Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 56: Asia-Pacific Breast Cancer Therapeutics Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 57: Asia-Pacific Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 58: Breast Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 59: Australian Breast Cancer Therapeutics Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 60: Australian Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

INDIA

TABLE 61: Indian Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 62: Indian Breast Cancer Therapeutics Historic Market Review by Product in US$ Million: 2009-2017

TABLE 63: Breast Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

SOUTH KOREA

TABLE 64: Breast Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 65: South Korean Breast Cancer Therapeutics Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 66: Breast Cancer Therapeutics Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 67: Rest of Asia-Pacific Market for Breast Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 68: Breast Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 69: Rest of Asia-Pacific Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 70: Latin American Breast Cancer Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 71: Breast Cancer Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 72: Latin American Breast Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 73: Latin American Breast Cancer Therapeutics Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 74: Breast Cancer Therapeutics Historic Market Analysis in Latin America in US$ Million by Product: 2009-2017

TABLE 75: Latin American Breast Cancer Therapeutics Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 76: Argentinean Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 77: Breast Cancer Therapeutics Market in Argentina in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 78: Argentinean Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

BRAZIL

TABLE 79: Breast Cancer Therapeutics Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 80: Brazilian Breast Cancer Therapeutics Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 81: Brazilian Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

MEXICO

TABLE 82: Breast Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 83: Mexican Breast Cancer Therapeutics Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 84: Mexican Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 85: Rest of Latin America Breast Cancer Therapeutics Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 86: Breast Cancer Therapeutics Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2009-2017

TABLE 87: Rest of Latin America Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 88: The Middle East Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 89: Breast Cancer Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 90: The Middle East Breast Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 91: The Middle East Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 92: The Middle East Breast Cancer Therapeutics Historic Market by Product in US$ Million: 2009-2017

TABLE 93: Breast Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

IRAN

TABLE 94: Iranian Market for Breast Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 95: Breast Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 96: Iranian Breast Cancer Therapeutics Market Share Analysis by Product: 2009 VS 2019 VS 2025

ISRAEL

TABLE 97: Israeli Breast Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 98: Breast Cancer Therapeutics Market in Israel in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 99: Israeli Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 100: Saudi Arabian Breast Cancer Therapeutics Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 101: Breast Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2009-2017

TABLE 102: Saudi Arabian Breast Cancer Therapeutics Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 103: Breast Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 104: United Arab Emirates Breast Cancer Therapeutics Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 105: Breast Cancer Therapeutics Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 106: Breast Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 107: Rest of Middle East Breast Cancer Therapeutics Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 108: Rest of Middle East Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

AFRICA

TABLE 109: African Breast Cancer Therapeutics Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 110: Breast Cancer Therapeutics Market in Africa by Product: A Historic Review in US$ Million for 2009-2017

TABLE 111: African Breast Cancer Therapeutics Market Share Breakdown by Product: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC

CELGENE CORPORATION

EISAI CO.

ELI LILLY AND COMPANY

NOVARTIS INTERNATIONAL AG

PFIZER

ROCHE DIAGNOSTICS

SANOFI

TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astrazeneca Plc
  • Celgene Corporation
  • Eisai Co.
  • Eli Lilly and Company
  • Novartis International Ag
  • Pfizer
  • Roche Diagnostics
  • Sanofi
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll